#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Search results: (10000)



News What is new in the treatment of atopic dermatitis and how are comorbidities affecting it?

Allergic rhinitis, conjunctivitis, bronchial asthma, or autoimmune diseases like alopecia, vitiligo, celiac disease, and idiopathic inflammatory bowel diseases – these are comorbidities that often trouble patients with atopic dermatitis (AD). Modern systemic treatments bring new hope to these patients. "The primary benefit of targeted treatment, especially for severe AD, is the mitigation or elimination of chronic inflammation and persistent itching, significantly improving the quality of life for patients," says Chief Physician MUDr. Miroslav Nečas, Ph.D., from the 1st Department of Dermatovenereology of MU and St. Anne's University Hospital in Brno.
Source: Systemic treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis – Type 2 inflammation 26. 6. 2023

News Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer

Antibodies against the programmed cell death protein 1 (PD-1) improve the survival of patients with advanced non-small cell lung cancer (NSCLC). However, their use has not yet been tested in patients with resectable NSCLC. In 2018, the New England Journal of Medicine published the results of a pilot study of neoadjuvant therapy with nivolumab in patients with resectable NSCLC. Based on the promising results of this study, the investigative team subsequently decided to also test a combination of nivolumab and ipilimumab.
Source: Immunotherapy in Oncology 6. 11. 2020

News Treatment of Schizophrenia in Light of New Findings

"Mental disorders constitute a significant burden on society," began Assoc. Prof. MUDr. Martin Anders, Ph.D., head of the Psychiatric Clinic at the First Faculty of Medicine, Charles University and General University Hospital in Prague, during his presentation at the psychiatric symposium titled "A Chance for a Better Life with Schizophrenia Diagnosis," held on October 18, 2021, in Prague. His lecture focused on key issues in the treatment of schizophrenia, as well as on one of the recently registered antipsychotics—lurasidone.
Source: Modern Treatment of Schizophrenia 14. 12. 2021

News Comparison of EHL Products in the Treatment of Hemophilia A – Pharmacoeconomic Analysis

In the work presented below, whose results were recently published, a model combining pharmacokinetic and pharmacodynamic data was developed. With its help, the authors tried to compare the bleeding rates in hemophiliacs treated with various EHL products. At the same time, they focused on the cost-effectiveness of this treatment.
Source: Hemophilia with Movement 21. 5. 2021

News The Immune System in the Pathophysiology of ITP

From the perspective of the pathophysiology of immune thrombocytopenia (ITP), it appears that the etiology of this disease is very complex and involves both antibody and cellular immunity.
Source: Immune Thrombocytopenia 9. 4. 2022

News Efficacy and Safety of Bimekizumab in the Treatment of Moderate to Severe Plaque Psoriasis - BE READY Study Results

The interleukin 17 (IL-17) family represents a group of pro-inflammatory cytokines that play a crucial role in the pathogenesis of psoriasis. Inhibiting interleukins from this family has a significant anti-inflammatory effect and represents a promising therapeutic target for newly developed and applied drugs.
Source: Psoriasis 6. 5. 2022

Journal articles Education in schizophrenia: How patients and their relatives assess the relapse prevention programme PREDUKA

Author of the article: Lucie Bankovská Motlová, Eva Dragomirecká, Šárka Matelová, Renata Otevřelová, Radka Čermáková, Jan Čermák, Eva Lednická, Renata Hegedüšová, Tomáš Hübsch, Soňa Rothanzlová, Martinatomešová, Filip Španiel, Eva Kitzlerová Source: Časopis lékařů českých | 1/2010 1. 1. 2010

Journal articles Enteral nutrition in the treatment of inflammatory bowel disease

Author of the article: J. Schwarz, J. Sýkora, D. Cvalínová Source: Česko-slovenská pediatrie | 5/2017 9. 10. 2017

News Quality of Nutrition in ICU and Subsequent Quality of Life Are Closely Related

In the past decade, there has been a reduction in mortality associated with severe sepsis or acute respiratory failure. However, the number of people requiring care in rehabilitation facilities, moving to nursing homes, and never returning home has tripled. Therefore, experts' attention should now and in the future more intensively focus on the quality of life of patients, not just indicators such as mortality. Properly chosen nutrition contributes significantly to patients leaving intensive care units with good prospects for further recovery.
Source: Enteral Nutrition 6. 4. 2020

News Older patients with CLL and comorbidities: an option for treatment with immunotherapy without chemotherapy?

Is it time to treat chronic lymphocytic leukemia (CLL) without chemotherapy? The authors of a recently published article in the Expert Review of Hematology journal attempted to answer this question.
Source: Chronic Lymphocytic Leukemia 19. 1. 2021

News Pathogenetic Mechanisms Underlying the Development and Progression of Interstitial Lung Diseases

Interstitial lung processes (ILP) represent an umbrella term for a wide range of nosological units that differ from each other in clinical course, prognosis, and pathogenesis. Most ILPs are characterized by inflammation or fibrosis of the interstitial space, leading to impaired gas exchange at the alveolocapillary membrane.
Source: Progressive Interstitial Pulmonary Processes 6. 12. 2022

News Does the emergence of resistance to cetuximab mean ineffectiveness of all anti-EGFR antibodies?

Colorectal cancer (CRC) cells respond to targeted therapy in different ways. Besides the desired outcome of cell death, CRC cells can adapt and survive through changes in their genome. It is important to recognize that the developed resistance to targeted therapy may, but does not necessarily, apply uniformly across a class of drugs or a single mechanism of action.
Source: Colorectal Cancer 12. 11. 2021

News View on the Treatment of Rheumatoid Arthritis with Baricitinib Using the NNT Indicator

Clinical parameters assessed by patients themselves are an important tool in evaluating the effectiveness of new drugs and are particularly significant in the evaluation of treatments for chronic painful conditions, such as rheumatoid arthritis (RA). An analysis of clinical trial results presented at the European Rheumatology e-Congress in June 2020 focused on the effectiveness of the Janus kinase inhibitor baricitinib on parameters assessed directly by patients. Effectiveness was analyzed using the NNT indicator.
Source: Biological Treatment 30. 11. 2020

News Critical Overview of Clinical Studies on EHL FVIII Preparations

An international team of experts recently published a comprehensive work evaluating the methodology used in clinical trials of various extended half-life (EHL) factor VIII (FVIII) products. Their work does not directly compare the individual products but aims to assess the results of key registration clinical trials from the perspective of the hematologist and everyday clinical practice.
Source: Hemophilia 1. 2. 2023

News Prophylaxis EHL products FVIII bring improvements in clinical and pharmacokinetic results

A freshly published real-world clinical practice study from Spain highlights the experience of switching patients with hemophilia A in a prophylaxis setting from standard half-life products to newer products with an extended elimination half-life.
Source: Hemophilia 8. 8. 2022

News Role and Possibilities of Telemedicine in the Management of Hemophilia Care

A team of Irish experts recently evaluated the current possibilities of telemedicine in the care of individuals with hemophilia – not only from the perspective of care provided by specialized comprehensive centers but also considering physiotherapy and dental care.
Source: Hemophilia with Movement 22. 4. 2021

Journal articles Type 1 and 2 diabetes and pregnancy

Author of the article: L. Féderová, M. Korbeľ, Z. Nižňanská Source: Praktická gynekologie | 2/2010 23. 7. 2010

News Prevention of Skeletal Events in the Therapy of Patients with Advanced Prostate Cancer

Prostate cancer most commonly forms metastases in the bones. In patients with this advanced disease, skeletal events occur, negatively affecting their quality of life. Zoledronic acid and denosumab are used to prevent their occurrence, and their results in this indication were evaluated and compared in the cited study below.
Source: Prevention of Bone Events 9. 4. 2022

News Doc. Milan Sova: AAT substitution is available to all indicated patients. It is therefore crucial to now educate about the necessity of regular treatment

Alpha-1-antitrypsin deficiency (AATD) is one of the most common genetic disorders in adults. It is usually associated with the early development of chronic obstructive pulmonary disease (COPD) or liver damage. We discuss how modern substitution therapy can change patients' prognosis and when to consider this diagnosis with the head of the Clinic of Pulmonary Diseases and Tuberculosis at Masaryk University Faculty of Medicine and Brno University Hospital, Doc. MUDr. Milan Sova, Ph.D.
Source: Deficiency of Alpha-1-Antitrypsin 18. 1. 2024

Journal articles Hereditary angioedema –  neglected diagnosis

Author of the article: P. Králíčková, E. Burešová, T. Freiberger, I. Tachecí Source: Vnitřní lékařství | 9/2010 7. 9. 2010

Journal articles Type 2 diabetes mellitus in old age

Author of the article: MUDr. Martina Lášticová Source: Geriatrie a Gerontologie | 2/2014 26. 6. 2014

News Increased Sympathetic Activity in Patients with Masked Uncontrolled Hypertension

Not all hypertensive patients who have normal blood pressure readings in the doctor's office actually have controlled hypertension. Recent studies suggest that so-called masked uncontrolled hypertension may be linked to increased sympathetic activity.
Source: Cardiovascular Continuum 25. 1. 2021

News Effect of Zolpidem on Sleep Quality and Other Parameters in Patients During the Perioperative Period

Sleep quality is an important factor influencing functional outcomes, pain intensity, and patient satisfaction during the perioperative period. Sleep disturbances are a common problem among patients post-surgery. A prospective study evaluated the effect of zolpidem on sleep quality and other parameters in patients undergoing total hip arthroplasty for advanced osteoarthritis.
Source: Geriatric Patient 9. 9. 2020

News Even in Severe Cases of HAE, Individualized Treatment is Crucial – Case Study

As part of the case seminar from the HAExpert series, held on December 1, 2021, which specifically focused on the treatment of hereditary angioedema (HAE) in specific patients, Dr. Roman Hakl from the Institute of Clinical Immunology and Allergology at MU Faculty of Medicine and St. Anne's University Hospital in Brno presented the case of a now 34-year-old woman with HAE and obesity (BMI 37 kg/m2), who additionally has a positive family history – the disease was also diagnosed in her mother, sister, and son.
Source: Hereditary Angioedema 25. 2. 2022

News Colours of Sepsis 2023: Antimicrobial Stewardship is a Necessity. The Spectrum of Effective Antimicrobial Modalities has Expanded to Include Another Combination

Inappropriate antibiotic (ATB) treatment is associated with high mortality, while unrestricted use of broad-spectrum antibiotics drives resistance development. Thus, the decision to deploy antibiotics becomes a choice between the current and future patient. Antimicrobial stewardship (AMS) is an essential strategy in daily operations. Extending the spectrum of antimicrobial agents is equally crucial in combatting resistant bacterial strains. A symposium on this theme was part of the expert program at this year's 'festival of intensive medicine' Colours of Sepsis, held in late January in Ostrava.
Source: Anti-Infectives 9. 2. 2023

1 28 29 30 31 32 400
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#